We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+1.47%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$1.37B
AUM Growth
+$12.7M
Cap. Flow
+$12.7M
Cap. Flow %
0.93%
Top 10 Hldgs %
38.99%
Holding
271
New
23
Increased
77
Reduced
83
Closed
11

Top Buys

Rank Stock Value
1
VRT icon
Vertiv
VRT
+$3.04M
2
BNY
Bank of New York Mellon
BNY
+$1.74M
3
STT icon
State Street
STT
+$1.33M
4
MSFT icon
Microsoft
MSFT
+$1.31M
5
JPM icon
JPMorgan Chase
JPM
+$974K

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$2.48M
2
CVS icon
CVS Health
CVS
+$1.9M
3
AAPL icon
Apple
AAPL
+$1.75M
4
ON icon
ON Semiconductor
ON
+$1M
5
CLF icon
Cleveland-Cliffs
CLF
+$851K

Sector Composition

Rank Sector Weight
1 Technology 28.17%
2 Industrials 14.48%
3 Healthcare 13.98%
4 Financials 13.9%
5 Communication Services 8.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHEL icon
51
Shell
SHEL
$245B
$6.32M 0.46%
100,895
-7,530
-7% -$493K
IBB icon
52
iShares Biotechnology ETF
IBB
$9.71B
$6.18M 0.45%
46,762
-40
-0.1% -$5.62K
GEV icon
53
GE Vernova
GEV
$264B
$6.04M 0.44%
18,378
-70
-0.4% -$21.9K
LIN icon
54
Linde
LIN
$226B
$5.71M 0.42%
13,639
-105
-0.8% -$47.9K
SPGI icon
55
S&P Global
SPGI
$120B
$5.68M 0.41%
11,406
ABT icon
56
Abbott
ABT
$187B
$5.49M 0.4%
48,570
-300
-0.6% -$34.7K
WAB icon
57
Wabtec
WAB
$49.3B
$5.43M 0.4%
28,626
ISRG icon
58
Intuitive Surgical
ISRG
$134B
$4.85M 0.35%
9,297
MKL icon
59
Markel Group
MKL
$23.2B
$4.79M 0.35%
2,778
-145
-5% -$241K
HUBB icon
60
Hubbell
HUBB
$27.2B
$4.76M 0.35%
11,369
VRT icon
61
Vertiv
VRT
$105B
$4.72M 0.34%
41,555
+25,585
+160% +$3.04M
XLY icon
62
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.8B
$4.25M 0.31%
37,880
BNY
63
Bank of New York Mellon
BNY
$107B
$3.84M 0.28%
49,935
+22,506
+82% +$1.74M
GS icon
64
Goldman Sachs
GS
$303B
$3.78M 0.28%
6,594
+710
+12% +$396K
KO icon
65
Coca-Cola
KO
$375B
$3.74M 0.27%
60,035
+6,760
+13% +$441K
BP icon
66
BP
BP
$107B
$3.72M 0.27%
125,813
-9,360
-7% -$281K
MOG.A icon
67
Moog Inc Class A
MOG.A
$12.8B
$3.63M 0.26%
18,442
-164
-0.9% -$33.7K
PANW icon
68
Palo Alto Networks
PANW
$297B
$3.56M 0.26%
19,546
-150
-0.8% -$28.3K
MU icon
69
Micron Technology
MU
$991B
$3.35M 0.24%
39,775
-170
-0.4% -$17.3K
GLW icon
70
Corning
GLW
$143B
$3.26M 0.24%
68,574
PYPL icon
71
PayPal
PYPL
$50.5B
$3.25M 0.24%
38,117
-50
-0.1% -$4.2K
AME icon
72
Ametek
AME
$58.2B
$3.06M 0.22%
16,990
-100
-0.6% -$18.2K
GDX icon
73
VanEck Gold Miners ETF
GDX
$27.4B
$2.92M 0.21%
86,003
DIS icon
74
Walt Disney
DIS
$181B
$2.89M 0.21%
25,994
-301
-1% -$31.6K
BMY icon
75
Bristol-Myers Squibb
BMY
$132B
$2.86M 0.21%
50,589
+10,400
+26% +$581K

Similar funds

Neville Rodie & Shaw's Q4 2024 Portfolio in Review

As of Q4 2024, Neville Rodie & Shaw held 271 positions worth $1.37B, up 0.93% from $1.36B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Neville Rodie & Shaw's Q4 2024 filing shows 23 new, 77 increased, 83 reduced and 11 closed positions. Its largest new stake was Willis Towers Watson: 2,832 shares worth $887K. The largest sale was Qualcomm, an estimated $2.48M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Industrials and Healthcare.

  • Neville Rodie & Shaw's largest Q4 2024 buy was Willis Towers Watson: 2,832 shares worth $887K.
  • Neville Rodie & Shaw added most to Vertiv in Q4 2024, an estimated $3.04M increase.
  • Neville Rodie & Shaw's biggest Q4 2024 reduction was Qualcomm, cutting an estimated $2.48M.
  • Neville Rodie & Shaw fully exited CVS Health in Q4 2024, selling an estimated $1.9M.
  • Neville Rodie & Shaw's ten largest holdings make up 39% of its $1.37B portfolio in Q4 2024.
  • Neville Rodie & Shaw opened 23 new positions and closed 11 in Q4 2024.
  • Neville Rodie & Shaw's portfolio value rose 0.93% quarter-over-quarter to $1.37B.

Based on Neville Rodie & Shaw's 13F filing for Q4 2024, filed 6 Jan 2025.